Veeva HCP 360 Trends Report

As the life sciences industry continues to advance HCP relationship management, omnichannel orchestration, and AI initiatives, it’s critical to stay on top of evolving engagement trends.

Each quarter, the Veeva HCP 360 Trends Report provides unique insights into global and regional HCP engagement trends based on an analysis of approximately 600 million HCP interactions across more than 80% of biopharmas worldwide.

Reach out to Veeva Business Consulting to learn how connected sales, marketing, and medical teams deliver a better customer experience.

Veeva HCP 360 Trends Report Q4 2025

The Most Impactful Ways Biopharma Will Use AI This Year to Accelerate Treatment Adoption

The Q4 2025 HCP 360 Trends Report focuses on the top uses of AI in commercial biopharma. Practical AI agents help rapidly deliver scientific data and strengthen relationships with HCPs.

Free text is the foundation for seamless HCP engagement

Field teams are the most direct and expensive way to build customer relationships. Yet most companies miss highly valuable engagement insights. Compliant free text is now an option for capturing nuanced conversation information.

Use AI for content engagement, not just creation

AI for content creation holds great potential. But first, the industry must address a usage gap: Volume is rising yet field teams use content in just 48% of meetings. AI agents increase engagement with content by surfacing relevant assets for more impactful interactions.

Joint medical-commercial KPIs create a structure that maximizes AI

Few organizations use cross-team KPIs for jointly serving customers in a coordinated way. Some 71% of top 20 biopharma executives say their operating model, not compliance, prevents such collaboration. With shared KPIs, AI agents help automate teaming and ensure each interaction with an HCP informs the next.

Read the report to learn the most effective uses of AI in commercial biopharma.